Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban

Publisher： Bentham Science Publishers

E-ISSN： 1875-6557 |13|1|41-46

ISSN： 1573-403x

Source： Current Cardiology Reviews, Vol.13, Iss.1, 2016-11, pp. : 41-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Oral anticoagulants in older adults with atrial fibrillation

By Bernacki Gwen   Becker Richard  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 4, 2013-11 ,pp. : 403-415

Springer Publishing Company

Access to resources Recommend Favorite

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation

By  

Current Cardiology Reviews, Vol. 10, Iss. 4, 2014-11 ,pp. : 297-302

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 2, 2016-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 14-20

Bentham Science Publishers

Access to resources Recommend Favorite